Australia; Health policy; Health technology assessment; History
Indexed keywords
AUSTRALIA;
DECISION MAKERS;
FEDERAL GOVERNMENTS;
HEALTH POLICY;
HEALTH TECHNOLOGY ASSESSMENT;
HEALTH TECHNOLOGY ASSESSMENTS;
STATE GOVERNMENTS;
WELL-COVERED;
AUSTRALIA;
GOVERNMENT;
GOVERNMENT REGULATION;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HEALTH PROGRAM;
HEALTH SERVICE;
MEDICARE;
PROSPECTIVE PAYMENT;
REVIEW;
Australian Government Productivity Commission. Research Report. Melbourne
Australian Government Productivity Commission. Impacts of advances in medical technology in Australia. Research Report. Melbourne: 2005. http://www.pc.gov.au/projects/study/ medicaltechnology.
Australian Department of Health & Ageing. Public summary documents. http://www.health.gov.au/internet/main/ publishing.nsf/Content/pbac-psd-psds- explained.
AHMAC Breast Cancer Screening Evaluation Committee. Canberra: Australian Institute of Health
AHMAC Breast Cancer Screening Evaluation Committee. Breast cancer screening in Australia: Future directions. Canberra: Australian Institute of Health; 1990.
AHMAC Cervical Cancer Screening Evaluation Steering Committee. Canberra: Australian Institute of Health
AHMAC Cervical Cancer Screening Evaluation Steering Committee. Cervical cancer screening in Australia: Options for change. Canberra: Australian Institute of Health; 1990.
Australian Institute of Health and Welfare. Australia's health 2008. Canberra: AIHW; 2008. http://www.aihw.gov.au/ publications/index.cfm/title/ 10585.
ASERNIP-S Report No. 60. Adelaide: ASERNIP-S; June
Cameron A, Watt A, Lathlean T, et al. Rapid versus full systematic reviews: An inventory of current methods and practice in Health Technology Assessment. ASERNIP-S Report No. 60. Adelaide: ASERNIP-S; June 2007.
Commonwealth Department of Human Services and Health. Canberra: Australian Government Publishing Service
Commonwealth Department of Human Services and Health. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: Including major submissions involving economic analyses. Canberra: Australian Government Publishing Service; 1995.
Cost-effectiveness analysis and Australian health policy. Assessment of pharmaceuticals compared with the evaluation of some non-pharmaceutical technologies
Hailey D. Cost-effectiveness analysis and Australian health policy. Assessment of pharmaceuticals compared with the evaluation of some non-pharmaceutical technologies. Soc Sci Med. 1997;45:563-581.
The influence of health technology assessment on diffusion of MRI in Australia
Hailey DM, Crowe BL. The influence of health technology assessment on diffusion of MRI in Australia. Int J Technol Assess Health Care. 1993;10:522-529.
The role of value for money in public insurance coverage decisions for drugs in Australia: A retrospective analysis 1994-2004
Harris AH, Hill SR, Chin G, Li JJ,Walkom E. The role of value for money in public insurance coverage decisions for drugs in Australia: A retrospective analysis 1994-2004. Med Decis Making. 2008;28:713-722.
Medical Services Advisory Committee. Report of a review of the Medical Services Advisory Committee. Canberra: Department of Health and Ageing, 2005. http://www.msac.gov.au.
iHEA 2007 6th World Congress: Explorations in Health Economics Paper
Mitchell AS, Viney R. Learning from experience: Revision of the Australian Pharmaceutical Benefits Advisory Committee Guidelines. iHEA 2007 6th World Congress: Explorations in Health Economics Paper. http://ssrn.com/abstract = 993041.
(Chairman). Canberra: Australian Government Publishing Service
Sax S. (Chairman). Report of the committee on applications and costs of modern technology in medical practice. Canberra: Australian Government Publishing Service; 1978.
(Chairman). Canberra: Department of Community Services and Health
Selby-Smith C. (Chairman). Report of the committee to review to the role and function of the National Health Technology Advisory Panel. Canberra: Department of Community Services and Health; 1989.